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Abstract
Introduction: Although respiratory involvement has been described in patients with IBD, well-
defined interstitial lung disease has not been reported, especially among children with ulcerative
colitis.
Case presentation: Herein, we present a case of an adolescent female with ulcerative colitis and
extra-intestinal complications involving the lungs that were effectively treated with anti-metabolite
therapy.
Conclusion:  Children with UC may manifest either interstitial or large airway pulmonary
involvement. All children with suspected lung involvement should be screened for tuberculosis
prior to starting immunosuppressive therapy.
Introduction
The most prevalent pulmonary manifestation in either
Crohn's disease (CD) or ulcerative colitis (UC) is non-spe-
cific airway inflammation [1-3]. Untreated, patients are at
risk for developing bronchiolitis obliterans with organiz-
ing pneumonia, tracheal stenosis and bronchiectasis
[4,5]. Although necrobiotic lung nodules are less com-
mon, they represent an important pulmonary manifesta-
tion of interstitial lung disease in patients with IBD [6]. In
Pediatrics, the pulmonary manifestations of IBD have
been recognized only in children with CD [7-9]. Herein,
we describe a pediatric patient with ulcerative colitis and
pulmonary manifestations that were effectively treated
with immunosuppressive therapy.
Case presentation
A 13.5 yr. old female with UC diagnosed a year prior, pre-
sented at a local hospital emergency room with a 1 month
history of abdominal pain and diarrhea that progressed to
frank hematochezia. Her symptoms were also associated
with fever, night sweats, malaise, decreased appetite and
weight loss. A chest and abdominal computerized tomog-
raphy (CT) scan showed a 4 cm nodule in the lingula (Fig.
1a) and 2 smaller nodules in the left lower lobe. A CT-
guided biopsy of the lingular mass showed no malig-
nancy, but marked alveolar inflammation. The patient
was also PPD negative, and all cultures, including blood,
sputum and lung tissue for bacteria, atypical mycobacte-
ria, virus and fungal organisms were negative.
The patient was transferred to The Johns Hopkins's Chil-
dren's Center for further evaluation. Pulmonary functions
testing showed mild obstructive, but no restrictive lung
disease. A transbronchial biopsy of the lingular mass ver-
ified the presence of a necrobiotic nodule, and repeat tis-
sue cultures were also negative. The patient continued to
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have frequent bloody diarrhea that was treated with intra-
venous corticosteroids, parenteral nutrition, antibiotics
and mesalamine therapy. The patient's symptoms
resolved within 5 days of initiating therapy. She was pre-
scribed 6-mercaptopurine (1 mg/Kg/day) upon discharge
from hospital, and has remained essentially asympto-
matic up to 3 years in follow-up. A repeat chest CT done
at 12 months post discharge showed complete resolution
of the 2 small left lower lobe lesions, however, the lingu-
lar lesion was replaced with a residual thin-walled cyst
measuring 2.4 × 3.4 cm in diameter (Fig. 1b).
Discussion
Although extra intestinal manifestations are relatively
common (13–45%) in patients with IBD [2], pulmonary
manifestations are considered rare [1-3]. Moreover, while
there have been reported cases of pulmonary manifesta-
tions in pediatric CD [7-9], this is the first reported case of
interstitial lung involvement in a child with UC. In com-
parison, Camus and coworkers have described a number
of pulmonary manifestations in adult patients with UC,
including bronchiolitis obliterans with organizing pneu-
monia, chronic bronchitis, bronchiectasis, bronchiolitis,
serositis and interstitial lung disease. Most (> 60%) of the
patients manifested pulmonary symptoms during periods
of quiescent bowel disease, and there was no correlation
between age at bowel disease onset, and either the time of
onset of respiratory symptoms or the degree of respiratory
involvement. Although 8 patients were diagnosed with
UC in childhood, all developed respiratory symptoms
during adulthood. Moreover, proctocolectomy was not
shown to be protective against a recurrence of pulmonary
symptoms [1].
In a study by Songur and coworkers, 66% of patients with
respiratory symptoms had abnormal pulmonary function
tests (PFTs) [10]. More importantly, abnormal PFT's (>
80%), including a reduction in expiratory flow were
detected during periods of increased bowel disease activ-
ity, as was also noted in pediatric case. In an Eastern Euro-
pean case series, 56% of patients with UC showed a
decrease in lung diffusion capacity with no radiographic
change. In that study, just 16.7% of these patients were
smokers [11]. Although these studies would support the
use of PFTs in diagnosing pulmonary disease and follow-
ing clinical responsiveness to therapy in patients with
IBD, the role of routine pulmonary testing has yet to be
determined [12]. Longitudinal epidemiological studies
may help define the true prevalence of pulmonary disease
in children with UC and identify whether risk factors,
including family history, smoking, and serological
biomarkers can predict this disease phenotype.
Conclusion
Children with UC may manifest either interstitial or large
airway pulmonary involvement. Albeit rare, patients may
present with life threatening complications of respiratory
disease. Our patient responded to systemic corticosteroid
and maintenance anti-metabolite therapy. While there is
no epidemiologic pediatric data on the incidence of either
infectious or inflammatory pulmonary complications in
children with UC, an infectious etiology would still need
to be excluded in all patients prior to implementing
immuno-modulatory therapy, as was done in our case
series. Moreover, all children should be screened for
tuberculosis through skin testing, especially now with the
increased use of biological therapies.
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Chest CT scan showing a well-circumscribed homogeneous  pulmonary mass (4 cm) within the lingual of the left lung in a  newly diagnosed child with ulcerative colitis Figure 1
Chest CT scan showing a well-circumscribed homo-
geneous pulmonary mass (4 cm) within the lingual of 
the left lung in a newly diagnosed child with ulcera-
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Consent
The patient's family had a chance to review the manu-
script and provide verbal consent for its submission for
publication.
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Follow-up (12 mo.) chest CT scan in the same patient on  maintenance 6-mercaptopurine therapy with a residual cavi- tary lesion within the lingual of the left lung Figure 2
Follow-up (12 mo.) chest CT scan in the same 
patient on maintenance 6-mercaptopurine therapy 
with a residual cavitary lesion within the lingual of 
the left lung.